Phenobarbital can lower blood pressure, and this effect is one of its most recognized side effects. At standard therapeutic doses, the drop is usually mild and temporary. At higher doses, particularly when given intravenously, blood pressure can fall more significantly. Hypotension is actually one of the main reasons phenobarbital has fallen out of favor for certain uses in parts of Europe.
How Phenobarbital Affects Blood Pressure
Phenobarbital belongs to the barbiturate class of drugs, which work by enhancing the activity of a calming brain chemical that slows down the central nervous system. This overall slowing effect extends beyond the brain to the cardiovascular system, reducing the signals that keep blood vessels constricted and the heart pumping forcefully. The result is a decrease in blood pressure, sometimes accompanied by changes in heart rate.
A study in children receiving intravenous phenobarbital found that blood pressure and heart rate responses were variable from patient to patient and didn’t follow a consistent pattern. No child in that study developed dangerously slow heart rates, but blood pressure did fluctuate. In newborn animal models, phenobarbital at standard anticonvulsant doses caused a transient drop in mean arterial blood pressure, with the effect lasting longer when the body was in an acidic state (such as during illness or poor oxygenation).
Oral Versus Intravenous Dosing
The route of administration matters considerably. Oral phenobarbital, taken daily for epilepsy or other chronic conditions, is absorbed gradually. Blood pressure effects at these doses tend to be subtle enough that many people never notice them. Intravenous phenobarbital, used in emergencies like prolonged seizures, delivers the drug much faster and in larger amounts. This is where clinically meaningful drops in blood pressure are most likely to occur. Hospital protocols for IV phenobarbital typically require continuous monitoring of heart rate, blood pressure, and oxygen levels precisely because of this risk.
Overdose and Toxicity
In overdose situations, blood pressure drops become a serious and potentially life-threatening concern. The classic pattern of barbiturate toxicity includes decreased breathing, low blood pressure, abnormal heart rate, reduced body temperature, and diminished reflexes. The cardiovascular collapse in severe cases requires aggressive treatment with IV fluids and medications to raise blood pressure. This is one reason barbiturate overdoses carry a high fatality risk compared to overdoses of newer seizure or anxiety medications.
Effects on Blood Pressure Medications
Phenobarbital creates an important and sometimes overlooked interaction with blood pressure medications. It powerfully activates the liver’s drug-processing enzymes, which speeds up how quickly your body breaks down other medications. This means if you take phenobarbital alongside common blood pressure drugs like beta-blockers (metoprolol, propranolol) or calcium channel blockers, those medications get cleared from your system faster than expected. The practical result is that your blood pressure medication may become less effective, potentially causing your blood pressure to rise rather than stay controlled.
This is a real clinical concern. Someone on a stable blood pressure regimen who starts phenobarbital could see their blood pressure climb because their antihypertensive drugs are being metabolized too quickly. The same enzyme-boosting effect also reduces the effectiveness of blood thinners, birth control pills, and asthma medications, among others.
Withdrawal Can Spike Blood Pressure
Stopping phenobarbital abruptly after regular use triggers a withdrawal syndrome that can include the opposite cardiovascular effect: a surge in nervous system activity. Withdrawal symptoms typically begin within 24 hours and can include sweating, fever, tremors, rapid heart rate, anxiety, and in severe cases, seizures and delirium. Fever generally peaks between 36 and 72 hours after the last dose and can last three to four days. Neurological symptoms like hallucinations tend to appear around the 72-hour mark.
This rebound in nervous system activity can push blood pressure upward, which is why tapering is essential. Conservative tapering schedules reduce the dose gradually, and some protocols recommend at least three days of inpatient monitoring during discontinuation. If severe withdrawal develops, restarting phenobarbital to stabilize the patient and then tapering more slowly is the standard approach.
Who Is Most at Risk for Low Blood Pressure
Certain groups are more vulnerable to phenobarbital’s blood pressure effects. Newborns receiving the drug for seizures require careful cardiovascular monitoring because their blood pressure regulation systems are immature. Older adults, who often already take blood pressure medications, face both the direct blood pressure lowering effect and the drug interaction risk described above. People with pre-existing low blood pressure or dehydration are also at higher risk, since their cardiovascular system has less reserve to compensate.
If you’re taking phenobarbital and notice symptoms like dizziness when standing, lightheadedness, or fainting, these could signal that the drug is lowering your blood pressure enough to affect daily function. The effect is dose-dependent: higher doses carry greater risk. Anyone taking phenobarbital alongside other blood pressure-lowering medications, sedatives, or alcohol faces compounded risk because these substances amplify each other’s cardiovascular effects.